CAMBRIDGE, Mass., Aug. 25, 2022 -- Aktis Oncology, a biotechnology company discovering and developing novel classes of targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, today announced...
Scott Weiner will be moderating a panel, The Partnering Conundrum: To Partner or Not to Partner, That is the Question..., at the Bio 2011 conference in Washington, D.C.
News | 06. 28. 2011
